{"gene":"RGS2","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1997,"finding":"RGS2 is a selective and potent GTPase-activating protein (GAP) for Gqα, but not Giα, Gsα, or G12/13α. RGS2 selectively binds Gqα in brain membranes and purified recombinant form, and potently inhibits Gq-directed activation of phospholipase Cβ1 in reconstituted phospholipid vesicles, being 10-fold more potent than RGS4.","method":"Pulldown from brain membranes, binding to purified recombinant Gqα, GTPase activity assays, reconstituted phospholipid vesicle PLCβ1 activation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — multiple in vitro reconstitution assays with purified proteins, selectivity confirmed across multiple Gα family members","pmids":["9405622"],"is_preprint":false},{"year":1998,"finding":"RGS2 stimulates the GTPase activity of Gqα and Gi1α in biochemical assays; the effect on Gi1α was only observed after reconstitution in phospholipid vesicles containing M2 muscarinic receptors. RGS2 also inhibits both Gq- and Gi-dependent responses in transfected cells.","method":"GTPase activity assays, phospholipid vesicle reconstitution, transfected cell signaling assays","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified proteins and functional cell assays","pmids":["9736641"],"is_preprint":false},{"year":1999,"finding":"G protein selectivity of RGS2 is determined by specific structural features: RGS2 is 5-fold more potent than RGS4 as an inhibitor of Gq-stimulated phosphoinositide hydrolysis in vivo, while RGS4 is 8-fold more potent for Gi-mediated signaling. Mutations in RGS2 that alter its switch I binding pocket and α8-α9 loop increase potency toward Gi without affecting Gq potency.","method":"In vivo phosphoinositide hydrolysis assays, mutagenesis, comparison with RGS4-Giα1 crystal structure","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with functional assays, structural comparison, replicated selectivity observations","pmids":["10567399"],"is_preprint":false},{"year":2000,"finding":"RGS2 is phosphorylated by PKC in vitro to near-stoichiometric levels, and also in intact COS7 cells in response to PKC activation. PKC phosphorylation decreases RGS2's capacity to attenuate GTP- and GTPγS-stimulated PLCβ activation and reduces its GAP activity in reconstituted proteoliposomes.","method":"In vitro kinase assay with purified PKC isoforms, intact cell phosphorylation assay (PMA), PLCβ activity assay, GAP activity in reconstituted proteoliposomes with P2Y1 receptor and Gqαβγ","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation with stoichiometry measurement, functional consequence in reconstituted system","pmids":["11063746"],"is_preprint":false},{"year":2001,"finding":"RGS2 contains a conserved N-terminal amphipathic α-helix that binds vesicles containing acidic phospholipids and is necessary and sufficient for plasma membrane localization. Expression of activated Gq increases RGS2 association with the plasma membrane and decreases nuclear accumulation. The N-terminus also directs nuclear accumulation of GFP, and RGS2 enters the nucleus by passive diffusion (lacks a nuclear import signal).","method":"Confocal microscopy of GFP-tagged RGS2, mutational analysis, biophysical analysis (vesicle binding), HEK293 cell fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including mutagenesis, live imaging, and biophysical assays in single study","pmids":["11278586"],"is_preprint":false},{"year":2002,"finding":"RGS2 directly inhibits adenylyl cyclase activity independently of its GAP activity. The N-terminal 19 amino acids of RGS2 are required for inhibition of cAMP accumulation and binding to adenylyl cyclase. RGS2 interacts directly with the C1 (but not C2) domain of type V adenylyl cyclase. Three specific N-terminal residues identified by alanine scanning are responsible for this inhibitory function.","method":"Deletion/alanine scanning mutagenesis, cAMP accumulation assays in HEK293 cells, in vitro binding to adenylyl cyclase domains","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis mapping interaction site, direct binding assay, functional assay in cells","pmids":["12604604"],"is_preprint":false},{"year":2003,"finding":"RGS2-deficient mice exhibit hypertension, renovascular abnormalities, persistent resistance vasoconstriction, and prolonged vasoconstrictor responses in vivo. Loss of RGS2 in vascular smooth muscle cells increases agonist potency and efficacy at P2Y receptors and slows Ca2+ signal termination kinetics.","method":"RGS2 knockout mouse model, telemetric blood pressure measurement, in vitro Ca2+ signaling in vascular smooth muscle cells","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined vascular phenotype and cellular mechanism","pmids":["12588882"],"is_preprint":false},{"year":2003,"finding":"GFP-RGS2 localizes to the nucleus in HEK293 cells and is selectively recruited to the plasma membrane by co-expression with Gsα, Gqα, or corresponding receptors (β2-adrenergic, AT1A angiotensin II). G protein mutants with reduced RGS affinity fail to recruit RGS2, indicating direct G protein binding mediates membrane recruitment.","method":"GFP-tagged RGS2 expression, confocal microscopy, co-expression with G protein mutants in HEK293 cells","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization with functional G protein binding linkage, single lab","pmids":["12920194"],"is_preprint":false},{"year":2004,"finding":"RGS2 binds directly and selectively to the third intracellular (i3) loop of the M1 muscarinic receptor (but not M2 or RGS16). The N-terminal region of RGS2 is necessary and sufficient for M1i3 binding. RGS2 forms a stable heterotrimeric complex with activated Gqα and M1i3. Deletion of the N-terminus abolishes effector antagonist activity but not GAP activity toward G11α.","method":"Direct binding assays (GST pulldown), co-localization by fluorescence microscopy, membrane phosphoinositide hydrolysis assay, truncation mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods, defined domain mapping, functional validation","pmids":["14976183"],"is_preprint":false},{"year":2004,"finding":"RGS2 functions as a mediator of the NO-cGMP pathway in vascular smooth muscle: cGMP analogs fail to inhibit vasopressin-triggered Ca2+ transients in smooth muscle cells from RGS2−/− resistance arteries despite normal PKG expression and activation, and the blood pressure-lowering effect of nitric oxide donor SNP is impaired in RGS2−/− mice.","method":"RGS2 knockout mice, blood pressure telemetry, Ca2+ signaling in freshly isolated resistance artery smooth muscle cells, PKG activity assay","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple cellular and in vivo functional readouts","pmids":["15563583"],"is_preprint":false},{"year":2005,"finding":"Spinophilin (SPL) scaffolds RGS2 to GPCRs by binding the N-terminal domain of RGS2 and the third intracellular loop of GPCRs, markedly increasing RGS2-mediated inhibition of α-adrenergic receptor Ca2+ signaling. The constitutively active αAR(A293E) mutant that cannot bind SPL is resistant to RGS2 inhibition. RGS2-mediated inhibition of αAR Ca2+ signaling is reduced in spl−/− cells.","method":"Co-immunoprecipitation, Xenopus oocyte expression system, Ca2+ signaling assays, αAR-βAR chimeras, knockout cell comparison","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, functional epistasis using spl−/− and rgs2−/− cells, mutant receptor validation","pmids":["15793568"],"is_preprint":false},{"year":2005,"finding":"RGS2 binds directly to the third intracellular loop of the α1A-adrenergic receptor (but not α1B or α1D), is recruited to the plasma membrane by unstimulated α1A-AR, and inhibits receptor and Gq/11 signaling. The N-terminus of RGS2 is required, and residues K219, S220, R238 within the α1A-AR i3 loop are essential for the interaction.","method":"GST pulldown (direct binding), fluorescence imaging, mutagenesis of receptor, functional signaling assays in cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — direct in vitro binding with mutagenesis, live-cell imaging with functional consequence","pmids":["15917235"],"is_preprint":false},{"year":2005,"finding":"RGS2 interacts with Gsα and multiple adenylyl cyclase isoforms (ACI, ACII, ACV, ACVI) in living HEK293 cells. BRET signals were detected between RGS2-Rluc and Gsα-GFP, and between GFP-RGS2 and ACII- or ACVI-Rluc. RGS2 also interacts with the β2-adrenergic receptor third intracellular loop (GST pulldown), and the receptor-RGS2 BRET signal is stabilized by co-expressed AC.","method":"BRET assay, confocal microscopy, GST pulldown with β2AR i3 loop","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — BRET in living cells plus GST pulldown, single lab","pmids":["16095880"],"is_preprint":false},{"year":2007,"finding":"N-terminal residues of RGS2 control its proteasomal degradation in HEK293 cells. An N-terminal RGS2 variant Q2L (found in hypertensive patients) shows significantly reduced expression and reduced inhibition of AT1 receptor-stimulated inositol phosphate accumulation, consistent with N-end rule-mediated ubiquitylation.","method":"Mutagenesis, immunoblotting, inositol phosphate accumulation assay in HEK293 cells","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis with functional assay, single lab","pmids":["17220356"],"is_preprint":false},{"year":2007,"finding":"RGS2 downregulation in dopamine neurons of the ventral tegmental area increases GABAB receptor–GIRK channel coupling efficiency. Repeated GHB exposure downregulates RGS2 and increases this coupling, providing a mechanism for GHB tolerance.","method":"Electrophysiology in VTA neurons of wild-type and RGS2-knockout mice, GHB exposure paradigm, molecular analysis","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 — electrophysiological measurements in knockout mice with defined molecular mechanism","pmids":["17965710"],"is_preprint":false},{"year":2007,"finding":"The unique dileucine motif adjacent to the RGS2 amphipathic helix, and the hydrophobic extension of this helix, mediate constitutive plasma membrane targeting. Disrupting this motif or membrane phospholipid composition reduces plasma membrane association and inhibitory function of RGS2, without affecting its binding to M1 receptor i3 loop or activated Gqα.","method":"Mutagenesis, GFP-RGS2 confocal microscopy, prenylation chimeras, phospholipid perturbation, signaling functional assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple mutants, domain swaps, lipid perturbation experiments linking localization to function","pmids":["17848575"],"is_preprint":false},{"year":2009,"finding":"RGS2 binds to eIF2Bε (eukaryotic initiation factor 2B epsilon subunit) and inhibits mRNA translation. This function maps to a 37-amino acid region within the conserved RGS domain, is distinct from GAP activity, and involves interference with the eIF2-eIF2B GTPase cycle required for translation initiation.","method":"Co-immunoprecipitation (RGS2–eIF2Bε), in vitro translation assay, domain mapping, eIF2-eIF2B GTPase cycle assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding shown by Co-IP, domain mapped, functional translation assay with mechanistic detail","pmids":["19736320"],"is_preprint":false},{"year":2009,"finding":"X-ray crystal structure of a triple-mutant RGS2 (with Gαi-directed activity) in complex with transition-state mimetic Gαi at 2.8 Å resolution revealed the structural basis of wild-type RGS2 selectivity for Gqα over Gαi/o. Three evolutionarily conserved residues weaken Gαi association by unfavorable geometry at the switch I binding pocket.","method":"X-ray crystallography, mutagenesis, GTPase activity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus mutagenesis functional validation","pmids":["19478087"],"is_preprint":false},{"year":2008,"finding":"A hypertension-associated RGS2 missense variant R44H, located within the N-terminal amphipathic α-helix, binds the plasma membrane less efficiently than wild-type RGS2. Tryptophan fluorescence and circular dichroism show that R44H prevents hydrophobic entrenchment into the lipid bilayer without disrupting helix formation, resulting in weaker inhibition of Gq signaling.","method":"Confocal microscopy (YFP-R44H), tryptophan fluorescence spectroscopy, circular dichroism, Gq signaling functional assay","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 — biophysical and cell biological assays defining structural mechanism of a disease variant","pmids":["18230714"],"is_preprint":false},{"year":2010,"finding":"RGS2 is a primary terminator of β2-adrenergic receptor–Gi signaling in cardiomyocytes. Selective upregulation of RGS2 upon agonist withdrawal impairs β2AR-Gi signaling; adenoviral RGS2 overexpression suppresses agonist-activated β2AR-Gi signaling, while RGS2 ablation sustains this signaling.","method":"Adult mouse cardiomyocyte culture, adenoviral RGS2 overexpression, RGS2 knockout, cAMP and contractility measurements","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — KO and OE with defined signaling readout, single lab","pmids":["21291891"],"is_preprint":false},{"year":2011,"finding":"β2-adrenoceptor agonist and glucocorticoid combinations synergistically induce RGS2 expression in human airway smooth muscle cells, and this induced RGS2 reduces intracellular Ca2+ flux elicited by Gq-coupled spasmogens. Rgs2-deficient mice show enhanced bronchoconstriction and absence of LABA-induced bronchoprotection.","method":"Primary human airway smooth muscle cell culture, Ca2+ flux assay, Rgs2-/- mouse model, methacholine challenge","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — human cell system plus knockout mouse, multiple functional readouts","pmids":["22080612"],"is_preprint":false},{"year":2015,"finding":"FBXO44, operating within a CUL4B/DDB1 E3 ubiquitin ligase complex (not the canonical CUL1/Skp1 complex), mediates RGS2 proteasomal degradation. This was identified by genomic siRNA screening.","method":"Genome-wide siRNA screen, co-immunoprecipitation, ubiquitylation assay, proteasome inhibitor treatment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA screen followed by Co-IP validation of CUL4B/DDB1/FBXO44 complex, single lab","pmids":["25970626"],"is_preprint":false},{"year":2015,"finding":"RGS2 protein is degraded via polyubiquitination at K71 residue, and is stabilized by the deubiquitinase MCPIP1; a catalytically dead C157A MCPIP1 mutant does not stabilize RGS2. RGS2 overexpression decreases TSPYL5 protein levels in breast cancer cells.","method":"Mutagenesis (K71R), MG-132 treatment, dominant-negative deubiquitinase mutant, immunoblot","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — site-directed mutagenesis of ubiquitination site and deubiquitinase functional validation, single lab","pmids":["25187114"],"is_preprint":false},{"year":2019,"finding":"RGS2 translation is controlled by its interaction with eIF2Bε: RGS2 or its eIF2B-interacting domain (RGS2eb) increases levels of ATF4 and CHOP at the translational level, independently of eIF2α phosphorylation, promoting expression of stress-related apoptotic factors.","method":"RGS2/RGS2eb overexpression, polysome analysis, immunoblot for ATF4 and CHOP, eIF2α phosphorylation status determination","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — domain-specific construct, translational assays showing eIF2α-independent mechanism, single lab","pmids":["30826455"],"is_preprint":false},{"year":2021,"finding":"RGS2 causes prolonged translational arrest in slow-cycling/dormant cancer cells through persistent eIF2α phosphorylation, mediated by proteasome-dependent degradation of ATF4 (an eIF2 phosphatase scaffold). RGS2 antagonism or phosphodiesterase 5 inhibitors reverse this translational arrest and promote ER stress-induced apoptosis.","method":"Proliferation-sensitive dye labeling, RGS2 overexpression/knockdown, eIF2α phosphorylation assays, ATF4 degradation assay, in vitro and xenograft in vivo models","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple cell lines and in vivo PDX models, mechanism linked to ATF4/proteasome pathway","pmids":["33393490"],"is_preprint":false},{"year":2020,"finding":"RGS2 forms a ternary complex with PAR4 and Gαq in live cells (shown by BRET), and co-expression of PAR4 and Gαq shifts RGS2 localization from cytoplasm to plasma membrane. RGS2 abolishes PAR4-activated ERK phosphorylation, calcium mobilization, and RhoA activity.","method":"BRET assay in live cells, confocal microscopy, ERK phosphorylation assay, Ca2+ mobilization assay, RhoA activity assay","journal":"Cell communication and signaling : CCS","confidence":"Medium","confidence_rationale":"Tier 2 — BRET-confirmed ternary complex, multiple functional readouts, single lab","pmids":["32517689"],"is_preprint":false},{"year":2011,"finding":"RGS2 directly binds STAT3 in the nucleus and represses STAT3-mediated transcriptional activation of Nox1. GFP-RGS2 concentrates in the nucleus, and TLR2 signaling, through PKC-η/PLD2, reduces RGS2 expression to derepress STAT3-mediated Nox1 induction.","method":"Co-immunoprecipitation (RGS2–STAT3), nuclear GFP-RGS2 localization by confocal microscopy, luciferase reporter assay for Nox1 promoter, siRNA knockdown","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional reporter assay, nuclear localization confirmed, single lab","pmids":["22120521"],"is_preprint":false},{"year":2000,"finding":"RGS2 and RGS4 bind purified recombinant β'-COP (a COPI subunit) in vitro; endogenous cytosolic RGS2 from HEK293T cells co-fractionates with the COPI complex by gel filtration. RGS4 inhibits COPI association with Golgi membranes and intracellular transport independently of its GAP activity, through dilysine motifs.","method":"In vitro binding to recombinant β'-COP, gel filtration co-fractionation, Golgi membrane COPI binding assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro binding and co-fractionation for RGS2, but functional COPI inhibition demonstrated mainly for RGS4","pmids":["10982407"],"is_preprint":false},{"year":2007,"finding":"RGS2 deficiency leads to increased renal responsiveness to vasopressin: RGS2 is expressed specifically in vasopressin-sensitive nephron segments, vasopressin rapidly upregulates RGS2 expression, and cAMP accumulation in microdissected collecting ducts is significantly higher in RGS2−/− mice.","method":"RGS2 knockout mice, microdissected collecting duct cAMP assay, in situ hybridization for localization, water restriction/loading test","journal":"Journal of the American Society of Nephrology : JASN","confidence":"Medium","confidence_rationale":"Tier 2 — KO with defined renal tubule cellular assay and in vivo phenotype, single lab","pmids":["17475820"],"is_preprint":false},{"year":2010,"finding":"Loss of renal RGS2 (by kidney cross-transplantation) is sufficient to cause hypertension, whereas absence of RGS2 from all extrarenal tissues (including peripheral vasculature) does not significantly alter blood pressure. This establishes that RGS2 acts within the kidney to modulate blood pressure.","method":"Kidney cross-transplantation between RGS2-deficient and wild-type mice, telemetric blood pressure measurement","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 — rigorous epistasis via organ transplantation strategy, defines tissue-specific mechanism","pmids":["20847141"],"is_preprint":false},{"year":2023,"finding":"RGS2 enhances estradiol biosynthesis in trophoblasts by promoting degradation of the transcription factor HAND1: RGS2 suppresses USP14-mediated deubiquitination of HAND1, leading to its proteasomal degradation and relief of HAND1-induced trans-repression of the aromatase gene. Conversely, aromatase binds RGS2 and represses its GAP activity.","method":"Co-immunoprecipitation (RGS2–HAND1, RGS2–aromatase, USP14–HAND1), ubiquitination assays, aromatase promoter reporter assay, E2 measurement, JEG-3 trophoblast cell line","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — multiple Co-IP interactions, functional promoter assay, deubiquitinase mechanism, single lab","pmids":["36653442"],"is_preprint":false},{"year":2023,"finding":"The lncRNA HITT, induced by IFN-γ via E2F1, coordinates with RGS2 by co-binding the 5' UTR of PD-L1 mRNA to reduce PD-L1 translation, thereby enhancing T cell-mediated cytotoxicity in a PD-L1-dependent manner.","method":"RNA immunoprecipitation (HITT and RGS2 binding to PD-L1 5'UTR), luciferase reporter (PD-L1 translation), T cell cytotoxicity assay, in vivo tumor models","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — RNA-protein interaction assay, translation reporter, functional immune assay; single lab","pmids":["37014700"],"is_preprint":false}],"current_model":"RGS2 is a selective GTPase-activating protein (GAP) for Gqα that attenuates Gq/11-coupled GPCR signaling by accelerating GTP hydrolysis and acting as an effector antagonist at the plasma membrane, to which it is targeted via an N-terminal amphipathic helix; it also directly inhibits adenylyl cyclase (types III/V/VI) through its N-terminus, is recruited to specific GPCRs (M1 mAChR, α1A-AR, PAR4) via direct interaction between its N-terminal domain and receptor third intracellular loops (facilitated by spinophilin scaffolding), undergoes PKC phosphorylation that reduces its GAP activity, is subject to N-end rule/FBXO44-CUL4B-DDB1-mediated proteasomal degradation, and possesses a G protein-independent function whereby a region within its RGS domain binds eIF2Bε to globally inhibit mRNA translation and selectively promote ATF4/CHOP expression under stress."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that RGS2 is a selective GAP for Gqα resolved which heterotrimeric G protein it regulates, distinguishing it from other RGS family members that preferentially target Gi.","evidence":"Pulldown from brain membranes and reconstituted PLC-β1 activation in phospholipid vesicles with purified proteins","pmids":["9405622"],"confidence":"High","gaps":["Structural basis of Gq selectivity not yet defined","In vivo physiological consequence unknown","Whether RGS2 has functions beyond GAP activity unknown"]},{"year":1999,"claim":"Mutagenesis mapped the structural determinants of Gq selectivity to the switch I binding pocket and α8-α9 loop, explaining why RGS2 discriminates against Giα while RGS4 does not.","evidence":"Structure-guided mutagenesis with in vivo phosphoinositide hydrolysis assays comparing RGS2 and RGS4","pmids":["10567399"],"confidence":"High","gaps":["No crystal structure of RGS2–Gqα complex","How selectivity operates at atomic resolution unclear"]},{"year":2000,"claim":"PKC phosphorylation was shown to reduce RGS2 GAP activity, establishing a feedback mechanism whereby Gq-activated PKC can attenuate RGS2 function and prolong signaling.","evidence":"In vitro kinase assay with purified PKC, stoichiometric phosphorylation, GAP activity in reconstituted proteoliposomes","pmids":["11063746"],"confidence":"High","gaps":["Phosphorylation site(s) not mapped","In vivo relevance of PKC-mediated regulation not tested"]},{"year":2001,"claim":"Identification of the N-terminal amphipathic helix as the plasma membrane targeting element explained how a cytosolic RGS protein accesses its membrane-localized G protein substrates.","evidence":"GFP-tagged RGS2 confocal microscopy, mutational analysis, and biophysical vesicle-binding assays in HEK293 cells","pmids":["11278586"],"confidence":"High","gaps":["Relative contribution of lipid binding vs. G protein binding to steady-state localization unclear","Nuclear function of RGS2 undefined"]},{"year":2002,"claim":"Discovery that the N-terminal 19 residues of RGS2 directly inhibit adenylyl cyclase (type V, C1 domain) independently of GAP activity revealed a second, non-canonical signaling function.","evidence":"Deletion and alanine-scanning mutagenesis, cAMP accumulation assays, in vitro binding to AC domains","pmids":["12604604"],"confidence":"High","gaps":["Whether AC inhibition occurs in physiological contexts not established","Specificity across all AC isoforms incomplete"]},{"year":2003,"claim":"RGS2-knockout mice exhibited hypertension and prolonged vasoconstriction, establishing the first in vivo physiological role as a negative regulator of vascular Gq signaling and blood pressure.","evidence":"RGS2−/− mouse, telemetric blood pressure, Ca2+ signaling in vascular smooth muscle cells","pmids":["12588882"],"confidence":"High","gaps":["Tissue(s) responsible for the blood pressure phenotype not dissected","Contribution of non-GAP functions to the phenotype unknown"]},{"year":2004,"claim":"Demonstrating that RGS2 binds directly to the M1 muscarinic receptor i3 loop via its N-terminus and forms a ternary complex with activated Gqα established a receptor-directed recruitment mechanism for RGS specificity.","evidence":"GST pulldown, fluorescence co-localization, truncation mutants, membrane phosphoinositide hydrolysis assay","pmids":["14976183"],"confidence":"High","gaps":["Generalizability to other Gq-coupled receptors not known","Whether the ternary complex operates identically in native tissue unclear"]},{"year":2005,"claim":"Spinophilin was identified as a scaffold that bridges RGS2 to GPCRs via their i3 loops, markedly enhancing RGS2-mediated signal termination — expanding the receptor coupling model to include a scaffolding component.","evidence":"Reciprocal co-immunoprecipitation, Xenopus oocyte Ca2+ signaling, spl−/− and rgs2−/− cells, αAR-βAR chimeras","pmids":["15793568"],"confidence":"High","gaps":["Whether spinophilin scaffolding applies to all RGS2-receptor pairs untested","Structural basis of the ternary RGS2–spinophilin–receptor complex unknown"]},{"year":2007,"claim":"N-terminal residues were found to control proteasomal degradation via an N-end rule-like pathway, with a hypertension-associated Q2L variant showing accelerated turnover and reduced Gq inhibition — linking protein stability to disease.","evidence":"Mutagenesis, immunoblotting of protein levels, inositol phosphate accumulation assay in HEK293 cells","pmids":["17220356"],"confidence":"Medium","gaps":["E3 ligase responsible not identified in this study","Whether Q2L is causative for hypertension or merely associated not proven"]},{"year":2009,"claim":"The crystal structure of a triple-mutant RGS2 complexed with Giα1 at 2.8 Å revealed that three conserved residues create unfavorable geometry at the switch I interface for Giα, providing the atomic-level explanation for Gq selectivity.","evidence":"X-ray crystallography at 2.8 Å, mutagenesis with GTPase activity assays","pmids":["19478087"],"confidence":"High","gaps":["Structure of wild-type RGS2 with Gqα not obtained","Dynamic aspects of selectivity not captured"]},{"year":2009,"claim":"Discovery that a 37-residue region within the RGS domain binds eIF2Bε and inhibits translation initiation established a G protein-independent function in global protein synthesis control.","evidence":"Co-immunoprecipitation, in vitro translation assay, domain mapping, eIF2–eIF2B GTPase cycle assay","pmids":["19736320"],"confidence":"High","gaps":["Physiological stimuli that activate this translational function not defined","Whether eIF2Bε binding and GAP activity are mutually exclusive unknown"]},{"year":2010,"claim":"Kidney cross-transplantation demonstrated that renal RGS2, not peripheral vascular RGS2, is the primary determinant of blood pressure, redefining the tissue site of RGS2's cardiovascular function.","evidence":"Kidney transplantation between RGS2−/− and wild-type mice with telemetric blood pressure monitoring","pmids":["20847141"],"confidence":"High","gaps":["Specific nephron cell type and downstream signaling pathway not fully resolved","Interplay between renal and vascular RGS2 under stress conditions unknown"]},{"year":2015,"claim":"Identification of FBXO44–CUL4B–DDB1 as the E3 ubiquitin ligase complex targeting RGS2, and K71 as a key ubiquitination site stabilized by deubiquitinase MCPIP1, defined the proteolytic turnover machinery controlling RGS2 abundance.","evidence":"Genome-wide siRNA screen, co-immunoprecipitation of CUL4B/DDB1/FBXO44, K71R mutagenesis, MCPIP1 overexpression","pmids":["25970626","25187114"],"confidence":"Medium","gaps":["How FBXO44 recognition of RGS2 relates to N-end rule pathway not integrated","Whether MCPIP1-RGS2 axis operates in vascular tissue not tested"]},{"year":2019,"claim":"The eIF2Bε-binding domain of RGS2 was shown to selectively upregulate ATF4 and CHOP translation independently of eIF2α phosphorylation, revealing a non-canonical integrated stress response activation mechanism.","evidence":"RGS2eb domain overexpression, polysome profiling, immunoblot for ATF4/CHOP, eIF2α phosphorylation status","pmids":["30826455"],"confidence":"Medium","gaps":["Whether endogenous RGS2 levels are sufficient to trigger this pathway unknown","Downstream consequences for cell fate decisions not fully explored"]},{"year":2021,"claim":"In dormant cancer cells, RGS2 was found to maintain translational arrest through persistent eIF2α phosphorylation coupled with proteasomal ATF4 degradation, and pharmacological reversal promoted ER stress-induced apoptosis — establishing a role in tumor dormancy.","evidence":"Slow-cycling cell isolation, RGS2 overexpression/knockdown, eIF2α phosphorylation, xenograft models, PDE5 inhibitor treatment","pmids":["33393490"],"confidence":"Medium","gaps":["Whether RGS2-mediated dormancy operates in all cancer types unknown","Mechanism connecting RGS2 to persistent eIF2α phosphorylation (vs. eIF2Bε inhibition) not reconciled"]},{"year":2023,"claim":"RGS2 was shown to co-bind PD-L1 mRNA 5ʹ UTR with lncRNA HITT to suppress PD-L1 translation, linking its translational control function to immune evasion, and separately to promote estradiol biosynthesis by targeting HAND1 for degradation via USP14 suppression.","evidence":"RNA immunoprecipitation, PD-L1 translation reporter, T cell cytotoxicity assay, co-IP of RGS2–HAND1/USP14, aromatase reporter","pmids":["37014700","36653442"],"confidence":"Medium","gaps":["Whether RGS2 binds PD-L1 mRNA directly or solely via HITT not resolved","HAND1 regulation mechanism awaits independent confirmation","Integration of GAP and translational functions in the same cell context not addressed"]},{"year":null,"claim":"A unified model explaining how RGS2 partitions between its GAP, adenylyl cyclase inhibitory, translational control, and nuclear transcriptional functions in specific physiological contexts remains unestablished.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structure of RGS2 bound to Gqα or eIF2Bε","Signal-dependent switching between membrane vs. nuclear vs. cytosolic functions not defined","Relative contributions of GAP vs. translational control functions to disease phenotypes not dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,3,17]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[16,23,24,31]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[31]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[26]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,7,15,18,25]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,7,26]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,27]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,5,6,8,9,10,11,25]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[16,23,24,31]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[16,23,31]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,18,24]}],"complexes":[],"partners":["GNAQ","GNA11","ADCY5","EIF2B5","PPP1R9B","FBXO44","STAT3","ZC3H12A"],"other_free_text":[]},"mechanistic_narrative":"RGS2 is a multifunctional signaling regulator best characterized as a selective GTPase-activating protein (GAP) for Gqα that terminates Gq/11-coupled GPCR signaling, with additional G protein-independent roles in translational control and transcriptional regulation. Its RGS domain accelerates GTP hydrolysis on Gqα with high selectivity determined by specific residues in the switch I binding pocket, while its N-terminal amphipathic helix targets the protein to the plasma membrane via acidic phospholipid binding and mediates direct inhibition of adenylyl cyclases (types V and others) and receptor coupling through interaction with third intracellular loops of specific GPCRs (M1 mAChR, α1A-AR, PAR4), a process scaffolded by spinophilin [PMID:9405622, PMID:19478087, PMID:12604604, PMID:14976183, PMID:15793568, PMID:32517689]. Independent of GAP activity, a 37-amino acid segment within the RGS domain binds eIF2Bε to inhibit global mRNA translation initiation and selectively upregulate ATF4/CHOP, sustaining translational arrest in dormant cancer cells and cooperating with the lncRNA HITT to suppress PD-L1 translation [PMID:19736320, PMID:33393490, PMID:37014700]. RGS2 protein turnover is controlled by N-end rule-related ubiquitination at K71 and FBXO44–CUL4B–DDB1 E3 ligase-mediated proteasomal degradation, with PKC phosphorylation additionally reducing GAP activity; loss of RGS2 in mice causes hypertension originating primarily from the kidney, enhanced bronchoconstriction, and prolonged vasoconstrictor responses [PMID:25970626, PMID:25187114, PMID:11063746, PMID:12588882, PMID:20847141, PMID:22080612]."},"prefetch_data":{"uniprot":{"accession":"P41220","full_name":"Regulator of G-protein signaling 2","aliases":["Cell growth-inhibiting gene 31 protein","G0/G1 switch regulatory protein 8"],"length_aa":211,"mass_kda":24.4,"function":"Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:11063746, PubMed:19478087). It is involved in the negative regulation of the angiotensin-activated signaling pathway (PubMed:28784619). Plays a role in the regulation of blood pressure in response to signaling via G protein-coupled receptors and GNAQ. Plays a role in regulating the constriction and relaxation of vascular smooth muscle (By similarity). Binds EIF2B5 and blocks its activity, thereby inhibiting the translation of mRNA into protein (PubMed:19736320)","subcellular_location":"Cell membrane; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P41220/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS2","total_profiled":1310},"omim":[{"mim_id":"620544","title":"PPP1R13B DIVERGENT TRANSCRIPT, NONCODING; PPP1R13BDT","url":"https://www.omim.org/entry/620544"},{"mim_id":"613297","title":"MEMBRANE-ASSOCIATED RING-CH FINGER PROTEIN 6; MARCHF6","url":"https://www.omim.org/entry/613297"},{"mim_id":"612407","title":"REGULATOR OF G PROTEIN SIGNALING 21; RGS21","url":"https://www.omim.org/entry/612407"},{"mim_id":"609757","title":"WILLIAMS-BEUREN REGION DUPLICATION SYNDROME","url":"https://www.omim.org/entry/609757"},{"mim_id":"608986","title":"CREB-REGULATED TRANSCRIPTION COACTIVATOR 3; CRTC3","url":"https://www.omim.org/entry/608986"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RGS2"},"hgnc":{"alias_symbol":[],"prev_symbol":["G0S8"]},"alphafold":{"accession":"P41220","domains":[{"cath_id":"1.10.167.10","chopping":"108-198","consensus_level":"high","plddt":96.9949,"start":108,"end":198}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P41220","model_url":"https://alphafold.ebi.ac.uk/files/AF-P41220-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P41220-F1-predicted_aligned_error_v6.png","plddt_mean":80.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS2","jax_strain_url":"https://www.jax.org/strain/search?query=RGS2"},"sequence":{"accession":"P41220","fasta_url":"https://rest.uniprot.org/uniprotkb/P41220.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P41220/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P41220"}},"corpus_meta":[{"pmid":"9405622","id":"PMC_9405622","title":"RGS2/G0S8 is a selective inhibitor of Gqalpha function.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9405622","citation_count":302,"is_preprint":false},{"pmid":"9736641","id":"PMC_9736641","title":"Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9736641","citation_count":253,"is_preprint":false},{"pmid":"12588882","id":"PMC_12588882","title":"Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice.","date":"2003","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12588882","citation_count":246,"is_preprint":false},{"pmid":"11027316","id":"PMC_11027316","title":"Regulation of T cell activation, anxiety, and male aggression by RGS2.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11027316","citation_count":232,"is_preprint":false},{"pmid":"15489855","id":"PMC_15489855","title":"Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15489855","citation_count":222,"is_preprint":false},{"pmid":"14976183","id":"PMC_14976183","title":"RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14976183","citation_count":188,"is_preprint":false},{"pmid":"17965710","id":"PMC_17965710","title":"RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area.","date":"2007","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17965710","citation_count":176,"is_preprint":false},{"pmid":"10567399","id":"PMC_10567399","title":"G protein selectivity is a determinant of RGS2 function.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10567399","citation_count":152,"is_preprint":false},{"pmid":"11906816","id":"PMC_11906816","title":"RGS2: a multifunctional regulator of G-protein signaling.","date":"2002","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11906816","citation_count":129,"is_preprint":false},{"pmid":"15793568","id":"PMC_15793568","title":"Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors.","date":"2005","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15793568","citation_count":118,"is_preprint":false},{"pmid":"12920194","id":"PMC_12920194","title":"Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.","date":"2003","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12920194","citation_count":114,"is_preprint":false},{"pmid":"10523302","id":"PMC_10523302","title":"A novel regulator of G protein signalling in yeast, Rgs2, downregulates glucose-activation of the cAMP pathway through direct inhibition of Gpa2.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10523302","citation_count":114,"is_preprint":false},{"pmid":"12604604","id":"PMC_12604604","title":"Identification of RGS2 and type V adenylyl cyclase interaction sites.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12604604","citation_count":111,"is_preprint":false},{"pmid":"11278586","id":"PMC_11278586","title":"Mechanisms governing subcellular localization and function of human RGS2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278586","citation_count":108,"is_preprint":false},{"pmid":"16095880","id":"PMC_16095880","title":"RGS2 interacts with Gs and adenylyl cyclase in living cells.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16095880","citation_count":103,"is_preprint":false},{"pmid":"18316676","id":"PMC_18316676","title":"Influence of RGS2 on anxiety-related temperament, personality, and brain function.","date":"2008","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18316676","citation_count":98,"is_preprint":false},{"pmid":"16380388","id":"PMC_16380388","title":"Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16380388","citation_count":88,"is_preprint":false},{"pmid":"15917235","id":"PMC_15917235","title":"Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15917235","citation_count":85,"is_preprint":false},{"pmid":"11063746","id":"PMC_11063746","title":"Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11063746","citation_count":85,"is_preprint":false},{"pmid":"16449965","id":"PMC_16449965","title":"Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16449965","citation_count":81,"is_preprint":false},{"pmid":"10692485","id":"PMC_10692485","title":"Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells.","date":"2000","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10692485","citation_count":81,"is_preprint":false},{"pmid":"15661972","id":"PMC_15661972","title":"Autonomic nervous system and blood pressure regulation in RGS2-deficient mice.","date":"2005","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15661972","citation_count":81,"is_preprint":false},{"pmid":"15563583","id":"PMC_15563583","title":"RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15563583","citation_count":81,"is_preprint":false},{"pmid":"15292363","id":"PMC_15292363","title":"Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15292363","citation_count":78,"is_preprint":false},{"pmid":"17220356","id":"PMC_17220356","title":"N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17220356","citation_count":75,"is_preprint":false},{"pmid":"19162436","id":"PMC_19162436","title":"Variant in RGS2 moderates posttraumatic stress symptoms following potentially traumatic event exposure.","date":"2008","source":"Journal of anxiety disorders","url":"https://pubmed.ncbi.nlm.nih.gov/19162436","citation_count":73,"is_preprint":false},{"pmid":"22080612","id":"PMC_22080612","title":"β2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22080612","citation_count":67,"is_preprint":false},{"pmid":"19478087","id":"PMC_19478087","title":"Structural determinants of G-protein alpha subunit selectivity by regulator of G-protein signaling 2 (RGS2).","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19478087","citation_count":66,"is_preprint":false},{"pmid":"9174164","id":"PMC_9174164","title":"Comparison of mRNA expression of two regulators of G-protein signaling, RGS1/BL34/1R20 and RGS2/G0S8, in cultured human blood mononuclear cells.","date":"1997","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9174164","citation_count":61,"is_preprint":false},{"pmid":"15090051","id":"PMC_15090051","title":"Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.","date":"2004","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15090051","citation_count":56,"is_preprint":false},{"pmid":"10614620","id":"PMC_10614620","title":"Dynamic regulation of RGS2 in bone: potential new insights into parathyroid hormone signaling mechanisms.","date":"2000","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10614620","citation_count":55,"is_preprint":false},{"pmid":"20362664","id":"PMC_20362664","title":"RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.","date":"2010","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/20362664","citation_count":52,"is_preprint":false},{"pmid":"25187114","id":"PMC_25187114","title":"RGS2 suppresses breast cancer cell growth via a MCPIP1-dependent pathway.","date":"2015","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25187114","citation_count":51,"is_preprint":false},{"pmid":"16950788","id":"PMC_16950788","title":"Up-regulation of endogenous RGS2 mediates cross-desensitization between Gs and Gq signaling in osteoblasts.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16950788","citation_count":51,"is_preprint":false},{"pmid":"19736320","id":"PMC_19736320","title":"Translational control by RGS2.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19736320","citation_count":49,"is_preprint":false},{"pmid":"11906535","id":"PMC_11906535","title":"Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain.","date":"2002","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11906535","citation_count":48,"is_preprint":false},{"pmid":"22057271","id":"PMC_22057271","title":"Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22057271","citation_count":48,"is_preprint":false},{"pmid":"19966055","id":"PMC_19966055","title":"Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse.","date":"2009","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19966055","citation_count":47,"is_preprint":false},{"pmid":"16517124","id":"PMC_16517124","title":"RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.","date":"2006","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/16517124","citation_count":47,"is_preprint":false},{"pmid":"33393490","id":"PMC_33393490","title":"RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33393490","citation_count":46,"is_preprint":false},{"pmid":"11418611","id":"PMC_11418611","title":"RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11418611","citation_count":46,"is_preprint":false},{"pmid":"10332086","id":"PMC_10332086","title":"New roles for RGS2, 5 and 8 on the ratio-dependent modulation of recombinant GIRK channels expressed in Xenopus oocytes.","date":"1999","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10332086","citation_count":45,"is_preprint":false},{"pmid":"11488592","id":"PMC_11488592","title":"Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells.","date":"2001","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/11488592","citation_count":42,"is_preprint":false},{"pmid":"36591293","id":"PMC_36591293","title":"Fatty acid metabolism is related to the immune microenvironment changes of gastric cancer and RGS2 is a new tumor biomarker.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36591293","citation_count":42,"is_preprint":false},{"pmid":"11007872","id":"PMC_11007872","title":"Muscarinic stimulation of alpha1E Ca channels is selectively blocked by the effector antagonist function of RGS2 and phospholipase C-beta1.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11007872","citation_count":41,"is_preprint":false},{"pmid":"7643615","id":"PMC_7643615","title":"Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31.","date":"1995","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/7643615","citation_count":39,"is_preprint":false},{"pmid":"28102109","id":"PMC_28102109","title":"Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.","date":"2017","source":"Journal of chemotherapy (Florence, Italy)","url":"https://pubmed.ncbi.nlm.nih.gov/28102109","citation_count":37,"is_preprint":false},{"pmid":"18398336","id":"PMC_18398336","title":"Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.","date":"2008","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/18398336","citation_count":37,"is_preprint":false},{"pmid":"20036967","id":"PMC_20036967","title":"Deregulation of RGS2 in cardiovascular diseases.","date":"2010","source":"Frontiers in bioscience (Scholar edition)","url":"https://pubmed.ncbi.nlm.nih.gov/20036967","citation_count":36,"is_preprint":false},{"pmid":"11968023","id":"PMC_11968023","title":"Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells.","date":"2002","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11968023","citation_count":34,"is_preprint":false},{"pmid":"16627589","id":"PMC_16627589","title":"RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells.","date":"2006","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16627589","citation_count":34,"is_preprint":false},{"pmid":"17728697","id":"PMC_17728697","title":"Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17728697","citation_count":34,"is_preprint":false},{"pmid":"18207159","id":"PMC_18207159","title":"RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18207159","citation_count":34,"is_preprint":false},{"pmid":"21291891","id":"PMC_21291891","title":"RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.","date":"2011","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/21291891","citation_count":33,"is_preprint":false},{"pmid":"17558307","id":"PMC_17558307","title":"Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication.","date":"2007","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17558307","citation_count":32,"is_preprint":false},{"pmid":"15914115","id":"PMC_15914115","title":"Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.","date":"2005","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/15914115","citation_count":32,"is_preprint":false},{"pmid":"11996904","id":"PMC_11996904","title":"Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 3',5'-monophosphate-mediated pathway in primary neonatal murine osteoblasts.","date":"2002","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/11996904","citation_count":32,"is_preprint":false},{"pmid":"15488171","id":"PMC_15488171","title":"RGS2-mediated regulation of Gqalpha.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488171","citation_count":32,"is_preprint":false},{"pmid":"27549302","id":"PMC_27549302","title":"Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.","date":"2016","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/27549302","citation_count":31,"is_preprint":false},{"pmid":"18347610","id":"PMC_18347610","title":"Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region.","date":"2008","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/18347610","citation_count":31,"is_preprint":false},{"pmid":"15292238","id":"PMC_15292238","title":"Role of regulator of G protein signaling 2 (RGS2) in Ca(2+) oscillations and adaptation of Ca(2+) signaling to reduce excitability of RGS2-/- cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292238","citation_count":31,"is_preprint":false},{"pmid":"16269576","id":"PMC_16269576","title":"NO-dependent blood pressure regulation in RGS2-deficient mice.","date":"2005","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16269576","citation_count":30,"is_preprint":false},{"pmid":"17848575","id":"PMC_17848575","title":"Unique hydrophobic extension of the RGS2 amphipathic helix domain imparts increased plasma membrane binding and function relative to other RGS R4/B subfamily members.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17848575","citation_count":30,"is_preprint":false},{"pmid":"17986358","id":"PMC_17986358","title":"Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets.","date":"2007","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17986358","citation_count":29,"is_preprint":false},{"pmid":"33440047","id":"PMC_33440047","title":"ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33440047","citation_count":28,"is_preprint":false},{"pmid":"25970626","id":"PMC_25970626","title":"FBXO44-Mediated Degradation of RGS2 Protein Uniquely Depends on a Cullin 4B/DDB1 Complex.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25970626","citation_count":27,"is_preprint":false},{"pmid":"18262772","id":"PMC_18262772","title":"Association of RGS2 and RGS5 variants with schizophrenia symptom severity.","date":"2008","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/18262772","citation_count":27,"is_preprint":false},{"pmid":"31865781","id":"PMC_31865781","title":"Reduced mRNA Expression of RGS2 (Regulator of G Protein Signaling-2) in the Placenta Is Associated With Human Preeclampsia and Sufficient to Cause Features of the Disorder in Mice.","date":"2019","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31865781","citation_count":27,"is_preprint":false},{"pmid":"37014700","id":"PMC_37014700","title":"Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/37014700","citation_count":26,"is_preprint":false},{"pmid":"24154666","id":"PMC_24154666","title":"Influence of RGS2 on sertraline treatment for social anxiety disorder.","date":"2013","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24154666","citation_count":26,"is_preprint":false},{"pmid":"17475820","id":"PMC_17475820","title":"Increased renal responsiveness to vasopressin and enhanced V2 receptor signaling in RGS2-/- mice.","date":"2007","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/17475820","citation_count":26,"is_preprint":false},{"pmid":"25740197","id":"PMC_25740197","title":"RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25740197","citation_count":26,"is_preprint":false},{"pmid":"27701409","id":"PMC_27701409","title":"RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.","date":"2016","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27701409","citation_count":26,"is_preprint":false},{"pmid":"21447383","id":"PMC_21447383","title":"Resistance to age-related, normal body weight gain in RGS2 deficient mice.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21447383","citation_count":25,"is_preprint":false},{"pmid":"30467386","id":"PMC_30467386","title":"Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30467386","citation_count":25,"is_preprint":false},{"pmid":"11322774","id":"PMC_11322774","title":"RGS2: regulation of expression and nuclear localization.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11322774","citation_count":24,"is_preprint":false},{"pmid":"10982407","id":"PMC_10982407","title":"RGS4 and RGS2 bind coatomer and inhibit COPI association with Golgi membranes and intracellular transport.","date":"2000","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10982407","citation_count":24,"is_preprint":false},{"pmid":"11755214","id":"PMC_11755214","title":"Second messengers regulate RGS2 expression which is targeted to the nucleus.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11755214","citation_count":23,"is_preprint":false},{"pmid":"24105430","id":"PMC_24105430","title":"RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells.","date":"2014","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24105430","citation_count":22,"is_preprint":false},{"pmid":"18230714","id":"PMC_18230714","title":"The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq.","date":"2008","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18230714","citation_count":22,"is_preprint":false},{"pmid":"11306654","id":"PMC_11306654","title":"RGS2 blocks slow muscarinic inhibition of N-type Ca(2+) channels reconstituted in a human cell line.","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11306654","citation_count":22,"is_preprint":false},{"pmid":"20032508","id":"PMC_20032508","title":"Ischemia induces regulator of G protein signaling 2 (RGS2) protein upregulation and enhances apoptosis in astrocytes.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20032508","citation_count":22,"is_preprint":false},{"pmid":"32517689","id":"PMC_32517689","title":"Regulators of G-protein signaling, RGS2 and RGS4, inhibit protease-activated receptor 4-mediated signaling by forming a complex with the receptor and Gα in live cells.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32517689","citation_count":22,"is_preprint":false},{"pmid":"26941169","id":"PMC_26941169","title":"Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury.","date":"2016","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26941169","citation_count":21,"is_preprint":false},{"pmid":"11832360","id":"PMC_11832360","title":"Oxytocin stimulation of RGS2 mRNA expression in cultured human myometrial cells.","date":"2002","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11832360","citation_count":21,"is_preprint":false},{"pmid":"22120521","id":"PMC_22120521","title":"RGS2 is a negative regulator of STAT3-mediated Nox1 expression.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22120521","citation_count":21,"is_preprint":false},{"pmid":"24973550","id":"PMC_24973550","title":"Regulator of G protein signaling 2 (RGS2) deficiency accelerates the progression of kidney fibrosis.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24973550","citation_count":21,"is_preprint":false},{"pmid":"20847141","id":"PMC_20847141","title":"Renal actions of RGS2 control blood pressure.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20847141","citation_count":21,"is_preprint":false},{"pmid":"25847876","id":"PMC_25847876","title":"MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25847876","citation_count":21,"is_preprint":false},{"pmid":"30305828","id":"PMC_30305828","title":"A bronchoprotective role for Rgs2 in a murine model of lipopolysaccharide-induced airways inflammation.","date":"2018","source":"Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30305828","citation_count":21,"is_preprint":false},{"pmid":"28107494","id":"PMC_28107494","title":"Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28107494","citation_count":21,"is_preprint":false},{"pmid":"24593135","id":"PMC_24593135","title":"Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study.","date":"2014","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24593135","citation_count":21,"is_preprint":false},{"pmid":"16733081","id":"PMC_16733081","title":"Cellular stress increases RGS2 mRNA and decreases RGS4 mRNA levels in SH-SY5Y cells.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16733081","citation_count":20,"is_preprint":false},{"pmid":"21438143","id":"PMC_21438143","title":"Association of RGS2 variants with panic disorder in a Japanese population.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21438143","citation_count":20,"is_preprint":false},{"pmid":"25339105","id":"PMC_25339105","title":"Expression and regulation of regulator of G-protein signaling protein-2 (RGS2) in equine and bovine follicles prior to ovulation: molecular characterization of RGS2 transactivation in bovine granulosa cells.","date":"2014","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/25339105","citation_count":20,"is_preprint":false},{"pmid":"28846187","id":"PMC_28846187","title":"Increased fear learning, spatial learning as well as neophobia in Rgs2-/- mice.","date":"2017","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28846187","citation_count":19,"is_preprint":false},{"pmid":"36653442","id":"PMC_36653442","title":"RGS2 promotes estradiol biosynthesis by trophoblasts during human pregnancy.","date":"2023","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36653442","citation_count":18,"is_preprint":false},{"pmid":"22922103","id":"PMC_22922103","title":"RGS2 is a component of the cellular stress response.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22922103","citation_count":18,"is_preprint":false},{"pmid":"30826455","id":"PMC_30826455","title":"RGS2 promotes the translation of stress-associated proteins ATF4 and CHOP via its eIF2B-inhibitory domain.","date":"2019","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/30826455","citation_count":17,"is_preprint":false},{"pmid":"24398995","id":"PMC_24398995","title":"Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.","date":"2013","source":"Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","url":"https://pubmed.ncbi.nlm.nih.gov/24398995","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":55757,"output_tokens":7881,"usd":0.142743},"stage2":{"model":"claude-opus-4-6","input_tokens":11916,"output_tokens":4079,"usd":0.242333},"total_usd":0.385076,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"RGS2 is a selective and potent GTPase-activating protein (GAP) for Gqα, but not Giα, Gsα, or G12/13α. RGS2 selectively binds Gqα in brain membranes and purified recombinant form, and potently inhibits Gq-directed activation of phospholipase Cβ1 in reconstituted phospholipid vesicles, being 10-fold more potent than RGS4.\",\n      \"method\": \"Pulldown from brain membranes, binding to purified recombinant Gqα, GTPase activity assays, reconstituted phospholipid vesicle PLCβ1 activation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro reconstitution assays with purified proteins, selectivity confirmed across multiple Gα family members\",\n      \"pmids\": [\"9405622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"RGS2 stimulates the GTPase activity of Gqα and Gi1α in biochemical assays; the effect on Gi1α was only observed after reconstitution in phospholipid vesicles containing M2 muscarinic receptors. RGS2 also inhibits both Gq- and Gi-dependent responses in transfected cells.\",\n      \"method\": \"GTPase activity assays, phospholipid vesicle reconstitution, transfected cell signaling assays\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins and functional cell assays\",\n      \"pmids\": [\"9736641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"G protein selectivity of RGS2 is determined by specific structural features: RGS2 is 5-fold more potent than RGS4 as an inhibitor of Gq-stimulated phosphoinositide hydrolysis in vivo, while RGS4 is 8-fold more potent for Gi-mediated signaling. Mutations in RGS2 that alter its switch I binding pocket and α8-α9 loop increase potency toward Gi without affecting Gq potency.\",\n      \"method\": \"In vivo phosphoinositide hydrolysis assays, mutagenesis, comparison with RGS4-Giα1 crystal structure\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with functional assays, structural comparison, replicated selectivity observations\",\n      \"pmids\": [\"10567399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS2 is phosphorylated by PKC in vitro to near-stoichiometric levels, and also in intact COS7 cells in response to PKC activation. PKC phosphorylation decreases RGS2's capacity to attenuate GTP- and GTPγS-stimulated PLCβ activation and reduces its GAP activity in reconstituted proteoliposomes.\",\n      \"method\": \"In vitro kinase assay with purified PKC isoforms, intact cell phosphorylation assay (PMA), PLCβ activity assay, GAP activity in reconstituted proteoliposomes with P2Y1 receptor and Gqαβγ\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation with stoichiometry measurement, functional consequence in reconstituted system\",\n      \"pmids\": [\"11063746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS2 contains a conserved N-terminal amphipathic α-helix that binds vesicles containing acidic phospholipids and is necessary and sufficient for plasma membrane localization. Expression of activated Gq increases RGS2 association with the plasma membrane and decreases nuclear accumulation. The N-terminus also directs nuclear accumulation of GFP, and RGS2 enters the nucleus by passive diffusion (lacks a nuclear import signal).\",\n      \"method\": \"Confocal microscopy of GFP-tagged RGS2, mutational analysis, biophysical analysis (vesicle binding), HEK293 cell fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including mutagenesis, live imaging, and biophysical assays in single study\",\n      \"pmids\": [\"11278586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"RGS2 directly inhibits adenylyl cyclase activity independently of its GAP activity. The N-terminal 19 amino acids of RGS2 are required for inhibition of cAMP accumulation and binding to adenylyl cyclase. RGS2 interacts directly with the C1 (but not C2) domain of type V adenylyl cyclase. Three specific N-terminal residues identified by alanine scanning are responsible for this inhibitory function.\",\n      \"method\": \"Deletion/alanine scanning mutagenesis, cAMP accumulation assays in HEK293 cells, in vitro binding to adenylyl cyclase domains\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis mapping interaction site, direct binding assay, functional assay in cells\",\n      \"pmids\": [\"12604604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"RGS2-deficient mice exhibit hypertension, renovascular abnormalities, persistent resistance vasoconstriction, and prolonged vasoconstrictor responses in vivo. Loss of RGS2 in vascular smooth muscle cells increases agonist potency and efficacy at P2Y receptors and slows Ca2+ signal termination kinetics.\",\n      \"method\": \"RGS2 knockout mouse model, telemetric blood pressure measurement, in vitro Ca2+ signaling in vascular smooth muscle cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined vascular phenotype and cellular mechanism\",\n      \"pmids\": [\"12588882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GFP-RGS2 localizes to the nucleus in HEK293 cells and is selectively recruited to the plasma membrane by co-expression with Gsα, Gqα, or corresponding receptors (β2-adrenergic, AT1A angiotensin II). G protein mutants with reduced RGS affinity fail to recruit RGS2, indicating direct G protein binding mediates membrane recruitment.\",\n      \"method\": \"GFP-tagged RGS2 expression, confocal microscopy, co-expression with G protein mutants in HEK293 cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional G protein binding linkage, single lab\",\n      \"pmids\": [\"12920194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RGS2 binds directly and selectively to the third intracellular (i3) loop of the M1 muscarinic receptor (but not M2 or RGS16). The N-terminal region of RGS2 is necessary and sufficient for M1i3 binding. RGS2 forms a stable heterotrimeric complex with activated Gqα and M1i3. Deletion of the N-terminus abolishes effector antagonist activity but not GAP activity toward G11α.\",\n      \"method\": \"Direct binding assays (GST pulldown), co-localization by fluorescence microscopy, membrane phosphoinositide hydrolysis assay, truncation mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods, defined domain mapping, functional validation\",\n      \"pmids\": [\"14976183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"RGS2 functions as a mediator of the NO-cGMP pathway in vascular smooth muscle: cGMP analogs fail to inhibit vasopressin-triggered Ca2+ transients in smooth muscle cells from RGS2−/− resistance arteries despite normal PKG expression and activation, and the blood pressure-lowering effect of nitric oxide donor SNP is impaired in RGS2−/− mice.\",\n      \"method\": \"RGS2 knockout mice, blood pressure telemetry, Ca2+ signaling in freshly isolated resistance artery smooth muscle cells, PKG activity assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple cellular and in vivo functional readouts\",\n      \"pmids\": [\"15563583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Spinophilin (SPL) scaffolds RGS2 to GPCRs by binding the N-terminal domain of RGS2 and the third intracellular loop of GPCRs, markedly increasing RGS2-mediated inhibition of α-adrenergic receptor Ca2+ signaling. The constitutively active αAR(A293E) mutant that cannot bind SPL is resistant to RGS2 inhibition. RGS2-mediated inhibition of αAR Ca2+ signaling is reduced in spl−/− cells.\",\n      \"method\": \"Co-immunoprecipitation, Xenopus oocyte expression system, Ca2+ signaling assays, αAR-βAR chimeras, knockout cell comparison\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, functional epistasis using spl−/− and rgs2−/− cells, mutant receptor validation\",\n      \"pmids\": [\"15793568\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RGS2 binds directly to the third intracellular loop of the α1A-adrenergic receptor (but not α1B or α1D), is recruited to the plasma membrane by unstimulated α1A-AR, and inhibits receptor and Gq/11 signaling. The N-terminus of RGS2 is required, and residues K219, S220, R238 within the α1A-AR i3 loop are essential for the interaction.\",\n      \"method\": \"GST pulldown (direct binding), fluorescence imaging, mutagenesis of receptor, functional signaling assays in cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct in vitro binding with mutagenesis, live-cell imaging with functional consequence\",\n      \"pmids\": [\"15917235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RGS2 interacts with Gsα and multiple adenylyl cyclase isoforms (ACI, ACII, ACV, ACVI) in living HEK293 cells. BRET signals were detected between RGS2-Rluc and Gsα-GFP, and between GFP-RGS2 and ACII- or ACVI-Rluc. RGS2 also interacts with the β2-adrenergic receptor third intracellular loop (GST pulldown), and the receptor-RGS2 BRET signal is stabilized by co-expressed AC.\",\n      \"method\": \"BRET assay, confocal microscopy, GST pulldown with β2AR i3 loop\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — BRET in living cells plus GST pulldown, single lab\",\n      \"pmids\": [\"16095880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"N-terminal residues of RGS2 control its proteasomal degradation in HEK293 cells. An N-terminal RGS2 variant Q2L (found in hypertensive patients) shows significantly reduced expression and reduced inhibition of AT1 receptor-stimulated inositol phosphate accumulation, consistent with N-end rule-mediated ubiquitylation.\",\n      \"method\": \"Mutagenesis, immunoblotting, inositol phosphate accumulation assay in HEK293 cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional assay, single lab\",\n      \"pmids\": [\"17220356\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS2 downregulation in dopamine neurons of the ventral tegmental area increases GABAB receptor–GIRK channel coupling efficiency. Repeated GHB exposure downregulates RGS2 and increases this coupling, providing a mechanism for GHB tolerance.\",\n      \"method\": \"Electrophysiology in VTA neurons of wild-type and RGS2-knockout mice, GHB exposure paradigm, molecular analysis\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiological measurements in knockout mice with defined molecular mechanism\",\n      \"pmids\": [\"17965710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The unique dileucine motif adjacent to the RGS2 amphipathic helix, and the hydrophobic extension of this helix, mediate constitutive plasma membrane targeting. Disrupting this motif or membrane phospholipid composition reduces plasma membrane association and inhibitory function of RGS2, without affecting its binding to M1 receptor i3 loop or activated Gqα.\",\n      \"method\": \"Mutagenesis, GFP-RGS2 confocal microscopy, prenylation chimeras, phospholipid perturbation, signaling functional assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple mutants, domain swaps, lipid perturbation experiments linking localization to function\",\n      \"pmids\": [\"17848575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RGS2 binds to eIF2Bε (eukaryotic initiation factor 2B epsilon subunit) and inhibits mRNA translation. This function maps to a 37-amino acid region within the conserved RGS domain, is distinct from GAP activity, and involves interference with the eIF2-eIF2B GTPase cycle required for translation initiation.\",\n      \"method\": \"Co-immunoprecipitation (RGS2–eIF2Bε), in vitro translation assay, domain mapping, eIF2-eIF2B GTPase cycle assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding shown by Co-IP, domain mapped, functional translation assay with mechanistic detail\",\n      \"pmids\": [\"19736320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"X-ray crystal structure of a triple-mutant RGS2 (with Gαi-directed activity) in complex with transition-state mimetic Gαi at 2.8 Å resolution revealed the structural basis of wild-type RGS2 selectivity for Gqα over Gαi/o. Three evolutionarily conserved residues weaken Gαi association by unfavorable geometry at the switch I binding pocket.\",\n      \"method\": \"X-ray crystallography, mutagenesis, GTPase activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus mutagenesis functional validation\",\n      \"pmids\": [\"19478087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A hypertension-associated RGS2 missense variant R44H, located within the N-terminal amphipathic α-helix, binds the plasma membrane less efficiently than wild-type RGS2. Tryptophan fluorescence and circular dichroism show that R44H prevents hydrophobic entrenchment into the lipid bilayer without disrupting helix formation, resulting in weaker inhibition of Gq signaling.\",\n      \"method\": \"Confocal microscopy (YFP-R44H), tryptophan fluorescence spectroscopy, circular dichroism, Gq signaling functional assay\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biophysical and cell biological assays defining structural mechanism of a disease variant\",\n      \"pmids\": [\"18230714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RGS2 is a primary terminator of β2-adrenergic receptor–Gi signaling in cardiomyocytes. Selective upregulation of RGS2 upon agonist withdrawal impairs β2AR-Gi signaling; adenoviral RGS2 overexpression suppresses agonist-activated β2AR-Gi signaling, while RGS2 ablation sustains this signaling.\",\n      \"method\": \"Adult mouse cardiomyocyte culture, adenoviral RGS2 overexpression, RGS2 knockout, cAMP and contractility measurements\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and OE with defined signaling readout, single lab\",\n      \"pmids\": [\"21291891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"β2-adrenoceptor agonist and glucocorticoid combinations synergistically induce RGS2 expression in human airway smooth muscle cells, and this induced RGS2 reduces intracellular Ca2+ flux elicited by Gq-coupled spasmogens. Rgs2-deficient mice show enhanced bronchoconstriction and absence of LABA-induced bronchoprotection.\",\n      \"method\": \"Primary human airway smooth muscle cell culture, Ca2+ flux assay, Rgs2-/- mouse model, methacholine challenge\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human cell system plus knockout mouse, multiple functional readouts\",\n      \"pmids\": [\"22080612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FBXO44, operating within a CUL4B/DDB1 E3 ubiquitin ligase complex (not the canonical CUL1/Skp1 complex), mediates RGS2 proteasomal degradation. This was identified by genomic siRNA screening.\",\n      \"method\": \"Genome-wide siRNA screen, co-immunoprecipitation, ubiquitylation assay, proteasome inhibitor treatment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA screen followed by Co-IP validation of CUL4B/DDB1/FBXO44 complex, single lab\",\n      \"pmids\": [\"25970626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RGS2 protein is degraded via polyubiquitination at K71 residue, and is stabilized by the deubiquitinase MCPIP1; a catalytically dead C157A MCPIP1 mutant does not stabilize RGS2. RGS2 overexpression decreases TSPYL5 protein levels in breast cancer cells.\",\n      \"method\": \"Mutagenesis (K71R), MG-132 treatment, dominant-negative deubiquitinase mutant, immunoblot\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — site-directed mutagenesis of ubiquitination site and deubiquitinase functional validation, single lab\",\n      \"pmids\": [\"25187114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RGS2 translation is controlled by its interaction with eIF2Bε: RGS2 or its eIF2B-interacting domain (RGS2eb) increases levels of ATF4 and CHOP at the translational level, independently of eIF2α phosphorylation, promoting expression of stress-related apoptotic factors.\",\n      \"method\": \"RGS2/RGS2eb overexpression, polysome analysis, immunoblot for ATF4 and CHOP, eIF2α phosphorylation status determination\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific construct, translational assays showing eIF2α-independent mechanism, single lab\",\n      \"pmids\": [\"30826455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RGS2 causes prolonged translational arrest in slow-cycling/dormant cancer cells through persistent eIF2α phosphorylation, mediated by proteasome-dependent degradation of ATF4 (an eIF2 phosphatase scaffold). RGS2 antagonism or phosphodiesterase 5 inhibitors reverse this translational arrest and promote ER stress-induced apoptosis.\",\n      \"method\": \"Proliferation-sensitive dye labeling, RGS2 overexpression/knockdown, eIF2α phosphorylation assays, ATF4 degradation assay, in vitro and xenograft in vivo models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell lines and in vivo PDX models, mechanism linked to ATF4/proteasome pathway\",\n      \"pmids\": [\"33393490\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RGS2 forms a ternary complex with PAR4 and Gαq in live cells (shown by BRET), and co-expression of PAR4 and Gαq shifts RGS2 localization from cytoplasm to plasma membrane. RGS2 abolishes PAR4-activated ERK phosphorylation, calcium mobilization, and RhoA activity.\",\n      \"method\": \"BRET assay in live cells, confocal microscopy, ERK phosphorylation assay, Ca2+ mobilization assay, RhoA activity assay\",\n      \"journal\": \"Cell communication and signaling : CCS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — BRET-confirmed ternary complex, multiple functional readouts, single lab\",\n      \"pmids\": [\"32517689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RGS2 directly binds STAT3 in the nucleus and represses STAT3-mediated transcriptional activation of Nox1. GFP-RGS2 concentrates in the nucleus, and TLR2 signaling, through PKC-η/PLD2, reduces RGS2 expression to derepress STAT3-mediated Nox1 induction.\",\n      \"method\": \"Co-immunoprecipitation (RGS2–STAT3), nuclear GFP-RGS2 localization by confocal microscopy, luciferase reporter assay for Nox1 promoter, siRNA knockdown\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional reporter assay, nuclear localization confirmed, single lab\",\n      \"pmids\": [\"22120521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"RGS2 and RGS4 bind purified recombinant β'-COP (a COPI subunit) in vitro; endogenous cytosolic RGS2 from HEK293T cells co-fractionates with the COPI complex by gel filtration. RGS4 inhibits COPI association with Golgi membranes and intracellular transport independently of its GAP activity, through dilysine motifs.\",\n      \"method\": \"In vitro binding to recombinant β'-COP, gel filtration co-fractionation, Golgi membrane COPI binding assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding and co-fractionation for RGS2, but functional COPI inhibition demonstrated mainly for RGS4\",\n      \"pmids\": [\"10982407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RGS2 deficiency leads to increased renal responsiveness to vasopressin: RGS2 is expressed specifically in vasopressin-sensitive nephron segments, vasopressin rapidly upregulates RGS2 expression, and cAMP accumulation in microdissected collecting ducts is significantly higher in RGS2−/− mice.\",\n      \"method\": \"RGS2 knockout mice, microdissected collecting duct cAMP assay, in situ hybridization for localization, water restriction/loading test\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined renal tubule cellular assay and in vivo phenotype, single lab\",\n      \"pmids\": [\"17475820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Loss of renal RGS2 (by kidney cross-transplantation) is sufficient to cause hypertension, whereas absence of RGS2 from all extrarenal tissues (including peripheral vasculature) does not significantly alter blood pressure. This establishes that RGS2 acts within the kidney to modulate blood pressure.\",\n      \"method\": \"Kidney cross-transplantation between RGS2-deficient and wild-type mice, telemetric blood pressure measurement\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rigorous epistasis via organ transplantation strategy, defines tissue-specific mechanism\",\n      \"pmids\": [\"20847141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RGS2 enhances estradiol biosynthesis in trophoblasts by promoting degradation of the transcription factor HAND1: RGS2 suppresses USP14-mediated deubiquitination of HAND1, leading to its proteasomal degradation and relief of HAND1-induced trans-repression of the aromatase gene. Conversely, aromatase binds RGS2 and represses its GAP activity.\",\n      \"method\": \"Co-immunoprecipitation (RGS2–HAND1, RGS2–aromatase, USP14–HAND1), ubiquitination assays, aromatase promoter reporter assay, E2 measurement, JEG-3 trophoblast cell line\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple Co-IP interactions, functional promoter assay, deubiquitinase mechanism, single lab\",\n      \"pmids\": [\"36653442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The lncRNA HITT, induced by IFN-γ via E2F1, coordinates with RGS2 by co-binding the 5' UTR of PD-L1 mRNA to reduce PD-L1 translation, thereby enhancing T cell-mediated cytotoxicity in a PD-L1-dependent manner.\",\n      \"method\": \"RNA immunoprecipitation (HITT and RGS2 binding to PD-L1 5'UTR), luciferase reporter (PD-L1 translation), T cell cytotoxicity assay, in vivo tumor models\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA-protein interaction assay, translation reporter, functional immune assay; single lab\",\n      \"pmids\": [\"37014700\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS2 is a selective GTPase-activating protein (GAP) for Gqα that attenuates Gq/11-coupled GPCR signaling by accelerating GTP hydrolysis and acting as an effector antagonist at the plasma membrane, to which it is targeted via an N-terminal amphipathic helix; it also directly inhibits adenylyl cyclase (types III/V/VI) through its N-terminus, is recruited to specific GPCRs (M1 mAChR, α1A-AR, PAR4) via direct interaction between its N-terminal domain and receptor third intracellular loops (facilitated by spinophilin scaffolding), undergoes PKC phosphorylation that reduces its GAP activity, is subject to N-end rule/FBXO44-CUL4B-DDB1-mediated proteasomal degradation, and possesses a G protein-independent function whereby a region within its RGS domain binds eIF2Bε to globally inhibit mRNA translation and selectively promote ATF4/CHOP expression under stress.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS2 is a multifunctional signaling regulator best characterized as a selective GTPase-activating protein (GAP) for Gqα that terminates Gq/11-coupled GPCR signaling, with additional G protein-independent roles in translational control and transcriptional regulation. Its RGS domain accelerates GTP hydrolysis on Gqα with high selectivity determined by specific residues in the switch I binding pocket, while its N-terminal amphipathic helix targets the protein to the plasma membrane via acidic phospholipid binding and mediates direct inhibition of adenylyl cyclases (types V and others) and receptor coupling through interaction with third intracellular loops of specific GPCRs (M1 mAChR, α1A-AR, PAR4), a process scaffolded by spinophilin [PMID:9405622, PMID:19478087, PMID:12604604, PMID:14976183, PMID:15793568, PMID:32517689]. Independent of GAP activity, a 37-amino acid segment within the RGS domain binds eIF2Bε to inhibit global mRNA translation initiation and selectively upregulate ATF4/CHOP, sustaining translational arrest in dormant cancer cells and cooperating with the lncRNA HITT to suppress PD-L1 translation [PMID:19736320, PMID:33393490, PMID:37014700]. RGS2 protein turnover is controlled by N-end rule-related ubiquitination at K71 and FBXO44–CUL4B–DDB1 E3 ligase-mediated proteasomal degradation, with PKC phosphorylation additionally reducing GAP activity; loss of RGS2 in mice causes hypertension originating primarily from the kidney, enhanced bronchoconstriction, and prolonged vasoconstrictor responses [PMID:25970626, PMID:25187114, PMID:11063746, PMID:12588882, PMID:20847141, PMID:22080612].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that RGS2 is a selective GAP for Gqα resolved which heterotrimeric G protein it regulates, distinguishing it from other RGS family members that preferentially target Gi.\",\n      \"evidence\": \"Pulldown from brain membranes and reconstituted PLC-β1 activation in phospholipid vesicles with purified proteins\",\n      \"pmids\": [\"9405622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Gq selectivity not yet defined\", \"In vivo physiological consequence unknown\", \"Whether RGS2 has functions beyond GAP activity unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mutagenesis mapped the structural determinants of Gq selectivity to the switch I binding pocket and α8-α9 loop, explaining why RGS2 discriminates against Giα while RGS4 does not.\",\n      \"evidence\": \"Structure-guided mutagenesis with in vivo phosphoinositide hydrolysis assays comparing RGS2 and RGS4\",\n      \"pmids\": [\"10567399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of RGS2–Gqα complex\", \"How selectivity operates at atomic resolution unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"PKC phosphorylation was shown to reduce RGS2 GAP activity, establishing a feedback mechanism whereby Gq-activated PKC can attenuate RGS2 function and prolong signaling.\",\n      \"evidence\": \"In vitro kinase assay with purified PKC, stoichiometric phosphorylation, GAP activity in reconstituted proteoliposomes\",\n      \"pmids\": [\"11063746\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site(s) not mapped\", \"In vivo relevance of PKC-mediated regulation not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of the N-terminal amphipathic helix as the plasma membrane targeting element explained how a cytosolic RGS protein accesses its membrane-localized G protein substrates.\",\n      \"evidence\": \"GFP-tagged RGS2 confocal microscopy, mutational analysis, and biophysical vesicle-binding assays in HEK293 cells\",\n      \"pmids\": [\"11278586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of lipid binding vs. G protein binding to steady-state localization unclear\", \"Nuclear function of RGS2 undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that the N-terminal 19 residues of RGS2 directly inhibit adenylyl cyclase (type V, C1 domain) independently of GAP activity revealed a second, non-canonical signaling function.\",\n      \"evidence\": \"Deletion and alanine-scanning mutagenesis, cAMP accumulation assays, in vitro binding to AC domains\",\n      \"pmids\": [\"12604604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AC inhibition occurs in physiological contexts not established\", \"Specificity across all AC isoforms incomplete\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"RGS2-knockout mice exhibited hypertension and prolonged vasoconstriction, establishing the first in vivo physiological role as a negative regulator of vascular Gq signaling and blood pressure.\",\n      \"evidence\": \"RGS2−/− mouse, telemetric blood pressure, Ca2+ signaling in vascular smooth muscle cells\",\n      \"pmids\": [\"12588882\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue(s) responsible for the blood pressure phenotype not dissected\", \"Contribution of non-GAP functions to the phenotype unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that RGS2 binds directly to the M1 muscarinic receptor i3 loop via its N-terminus and forms a ternary complex with activated Gqα established a receptor-directed recruitment mechanism for RGS specificity.\",\n      \"evidence\": \"GST pulldown, fluorescence co-localization, truncation mutants, membrane phosphoinositide hydrolysis assay\",\n      \"pmids\": [\"14976183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability to other Gq-coupled receptors not known\", \"Whether the ternary complex operates identically in native tissue unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Spinophilin was identified as a scaffold that bridges RGS2 to GPCRs via their i3 loops, markedly enhancing RGS2-mediated signal termination — expanding the receptor coupling model to include a scaffolding component.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, Xenopus oocyte Ca2+ signaling, spl−/− and rgs2−/− cells, αAR-βAR chimeras\",\n      \"pmids\": [\"15793568\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether spinophilin scaffolding applies to all RGS2-receptor pairs untested\", \"Structural basis of the ternary RGS2–spinophilin–receptor complex unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"N-terminal residues were found to control proteasomal degradation via an N-end rule-like pathway, with a hypertension-associated Q2L variant showing accelerated turnover and reduced Gq inhibition — linking protein stability to disease.\",\n      \"evidence\": \"Mutagenesis, immunoblotting of protein levels, inositol phosphate accumulation assay in HEK293 cells\",\n      \"pmids\": [\"17220356\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase responsible not identified in this study\", \"Whether Q2L is causative for hypertension or merely associated not proven\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The crystal structure of a triple-mutant RGS2 complexed with Giα1 at 2.8 Å revealed that three conserved residues create unfavorable geometry at the switch I interface for Giα, providing the atomic-level explanation for Gq selectivity.\",\n      \"evidence\": \"X-ray crystallography at 2.8 Å, mutagenesis with GTPase activity assays\",\n      \"pmids\": [\"19478087\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of wild-type RGS2 with Gqα not obtained\", \"Dynamic aspects of selectivity not captured\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Discovery that a 37-residue region within the RGS domain binds eIF2Bε and inhibits translation initiation established a G protein-independent function in global protein synthesis control.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro translation assay, domain mapping, eIF2–eIF2B GTPase cycle assay\",\n      \"pmids\": [\"19736320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological stimuli that activate this translational function not defined\", \"Whether eIF2Bε binding and GAP activity are mutually exclusive unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Kidney cross-transplantation demonstrated that renal RGS2, not peripheral vascular RGS2, is the primary determinant of blood pressure, redefining the tissue site of RGS2's cardiovascular function.\",\n      \"evidence\": \"Kidney transplantation between RGS2−/− and wild-type mice with telemetric blood pressure monitoring\",\n      \"pmids\": [\"20847141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific nephron cell type and downstream signaling pathway not fully resolved\", \"Interplay between renal and vascular RGS2 under stress conditions unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of FBXO44–CUL4B–DDB1 as the E3 ubiquitin ligase complex targeting RGS2, and K71 as a key ubiquitination site stabilized by deubiquitinase MCPIP1, defined the proteolytic turnover machinery controlling RGS2 abundance.\",\n      \"evidence\": \"Genome-wide siRNA screen, co-immunoprecipitation of CUL4B/DDB1/FBXO44, K71R mutagenesis, MCPIP1 overexpression\",\n      \"pmids\": [\"25970626\", \"25187114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How FBXO44 recognition of RGS2 relates to N-end rule pathway not integrated\", \"Whether MCPIP1-RGS2 axis operates in vascular tissue not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The eIF2Bε-binding domain of RGS2 was shown to selectively upregulate ATF4 and CHOP translation independently of eIF2α phosphorylation, revealing a non-canonical integrated stress response activation mechanism.\",\n      \"evidence\": \"RGS2eb domain overexpression, polysome profiling, immunoblot for ATF4/CHOP, eIF2α phosphorylation status\",\n      \"pmids\": [\"30826455\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether endogenous RGS2 levels are sufficient to trigger this pathway unknown\", \"Downstream consequences for cell fate decisions not fully explored\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"In dormant cancer cells, RGS2 was found to maintain translational arrest through persistent eIF2α phosphorylation coupled with proteasomal ATF4 degradation, and pharmacological reversal promoted ER stress-induced apoptosis — establishing a role in tumor dormancy.\",\n      \"evidence\": \"Slow-cycling cell isolation, RGS2 overexpression/knockdown, eIF2α phosphorylation, xenograft models, PDE5 inhibitor treatment\",\n      \"pmids\": [\"33393490\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RGS2-mediated dormancy operates in all cancer types unknown\", \"Mechanism connecting RGS2 to persistent eIF2α phosphorylation (vs. eIF2Bε inhibition) not reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"RGS2 was shown to co-bind PD-L1 mRNA 5ʹ UTR with lncRNA HITT to suppress PD-L1 translation, linking its translational control function to immune evasion, and separately to promote estradiol biosynthesis by targeting HAND1 for degradation via USP14 suppression.\",\n      \"evidence\": \"RNA immunoprecipitation, PD-L1 translation reporter, T cell cytotoxicity assay, co-IP of RGS2–HAND1/USP14, aromatase reporter\",\n      \"pmids\": [\"37014700\", \"36653442\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RGS2 binds PD-L1 mRNA directly or solely via HITT not resolved\", \"HAND1 regulation mechanism awaits independent confirmation\", \"Integration of GAP and translational functions in the same cell context not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A unified model explaining how RGS2 partitions between its GAP, adenylyl cyclase inhibitory, translational control, and nuclear transcriptional functions in specific physiological contexts remains unestablished.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structure of RGS2 bound to Gqα or eIF2Bε\", \"Signal-dependent switching between membrane vs. nuclear vs. cytosolic functions not defined\", \"Relative contributions of GAP vs. translational control functions to disease phenotypes not dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 3, 17]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [16, 23, 24, 31]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 7, 15, 18, 25]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 7, 26]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 5, 6, 8, 9, 10, 11, 25]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [16, 23, 24, 31]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [16, 23, 31]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 18, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNAQ\",\n      \"GNA11\",\n      \"ADCY5\",\n      \"EIF2B5\",\n      \"PPP1R9B\",\n      \"FBXO44\",\n      \"STAT3\",\n      \"ZC3H12A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}